Bob Greene is a co-founder of Contour Venture Partners. He has invested in all stages of venture capital across several industry sectors. Contour invests in early stage companies focused on information technology and the application of technology into the financial services, enterprise SaaS and digital media sectors. Bob’s investments include BounceX, Covr, Dstillery, Fevo, Pathgather, Punchbowl, Radius Networks, Scripta,, Slice, Source3, SwapDrive, Syndio, Trialjectory and Voxy.


Prior to launching Contour in 2006, Bob was one of the three managing partners of Flatiron Partners in New York City. The firm backed more than 50 companies with over $500 million of venture capital. Bob received a BS from the Wharton School of Business and an MBA from the MIT Sloan School of Management.


Dave Lissy is chairman of Bright Horizons Family Solutions (a publicly traded global provider of high-quality child care, and workplace employee services), where he was chief executive officer for 17 years growing the company to $2b in revenue and $8b in market value.


Dave is also chairman of the board at Redfin (publicly traded technology-powered residential real estate company), director of Jumpstart and chair of the board of trustees of Ithaca College, where he received his bachelor’s degree.


Satish Tadikonda is an entrepreneur in the life sciences and healthcare sectors. His current venture, Avigo, focuses on using healthcare information to optimize clinical trials.


Satish is also an Entrepreneur-in-Residence at the Rock Center for Entrepreneurship at Harvard Business School, a member of TiE Angels and co-founder of TiE ScaleUp. He is deeply involved with many startups, helping them overcome typical barriers to growth by optimizing their strategic positioning, operations, sales and competitive advantage. Satish is a member of the Board of Directors of Scripta, ConnectM and Gateway for Cancer Research, and serves as an advisor to Clearmotion Inc.


Satish holds a Doctorate in Electrical and Computer Engineering, with a focus on medical imaging, from the University of Iowa and a Bachelor’s in Electrical and Electronics Engineering from the Birla Institute of Technology and Science, Pilani.


Russ Wilcox is a partner at Pillar VC, where he backs early stage Boston companies in technology and science fields such as AI applications, digital health, connected devices, quantum computing, blockchain, 3D software, AgTech, robotics, and synthetic biology. Previously, he co-founded E Ink Corporation to commercialize electronic paper invented at MIT and built a global materials and manufacturing business that sold for half a billion dollars.


Russ graduated with honors in Applied Mathematics from Harvard College and was a Baker Scholar at the Harvard Business School. He holds thirty-five issued U.S. patents. He is an Ernst & Young New England Entrepreneur of the Year and a Mass High Tech All-Star.


Michael K. Crossen is a partner and business lawyer with Foley & Lardner LLP. Michael provides government relations representation to clients, including private equity firms and hedge funds, and portfolio companies of each.


He works with members of the U.S. House of Representatives and the Senate to shape legislation and administrative action and has a Republican public affairs presence across the United States. Michael also offers general counsel and strategic advice to various corporations, with concentrations in commercial and business transactions.


In addition, Michael handles transactional negotiations and dispute resolutions, as well as business and real estate purchase agreements, loan and surety agreements and settlement agreements. He represents businesses before boards and administrative agencies and in all forms of dispute resolution.


40 Grove St, Suite 270 Wellesley, MA 02482

  • LinkedIn - White Circle
  • Facebook - White Circle
  • Twitter - White Circle
  • YouTube - White Circle


© Copyright 2020 Scripta Insights, Inc. 

Scripta™ is neither a pharmacy nor a doctor. The benefit service does not tell you what drug to take and does not participate in the drug selection process. Only your physician can determine the medications that are right for you. These alternative medications are options for less costly drugs that physicians may prescribe in place of the medications you are taking now. Scripta has reviewed your current medications only for the purpose of identifying potential cost savings for you to consider with your physician. Scripta has not analyzed the effectiveness or other therapeutic aspects of these medication alternatives. Accordingly, this report and any other forms of communication received from Scripta are not, nor should they be interpreted as, any form of treatment, drug regimen review, or provision of counseling or consultation by a prescriber, pharmacist or pharmacy. Do not stop taking your medication, change your medication, or start taking a new medication without being directed to do so by your physician and filling the prescription under the oversight of a licensed pharmacist. The alternatives set forth above may not be equivalent to your current medication, may interact adversely with your other medications, may not be indicated in light of your other conditions, may cause different or severe side effects, or may be less effective at treating your condition. Medication prices are approximate based on information provided by your pharmacy benefits manager, insurance plans, and/or employer, and may vary from pharmacy to pharmacy. Check with your insurance plan to obtain a full list of pharmacies where your prescriptions can be filled. All information herein is HIPAA protected, treated as highly confidential, and never shared with your employer.

Scripta™, Scripta Insights™ and The Best Meds at the Best Price® are registered trademarks of Scripta Insights, Inc. The contents of the site are for informational purposes only and not intended as a substitute for professional medical advice, diagnosis, or treatment. We do not recommend or endorse any specific prescription drug or pharmacy that may be mentioned herein. Reliance on any information provided by us, our affiliates, employees or others is solely at your own risk.